Hatanaka Yukako, Hobara Narumi, Honghua Jin, Akiyama Shinji, Nawa Hideki, Kobayashi Yuta, Takayama Fusako, Gomita Yutaka, Kawasaki Hiromu
Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
J Pharmacol Exp Ther. 2006 Feb;316(2):490-7. doi: 10.1124/jpet.105.094656. Epub 2005 Oct 19.
The effects of nonselective nitric-oxide synthase (NOS) inhibitors [N-omega-nitro-L-arginine methyl ester (L-NAME) and N-omega-nitro-L-arginine (L-NNA)] and specific neuronal NOS (nNOS) inhibitor [vinyl-L-N-5-(1-imino-3-butenyl)-L-ornithine (L-VNIO)] on adrenergic nerve-mediated vasoconstriction were studied in rat perfused mesenteric vascular beds without endothelium. Perfusion of L-NAME, L-NNA, or l-VNIO markedly augmented vasoconstrictor responses to periarterial nerve stimulation (PNS; 2-8 Hz) without affecting vasoconstriction induced by exogenously injected norepinephrine (NE). Addition of L-arginine, a precursor for the synthesis of nitric oxide (NO), reversed the augmentation of the PNS response by l-NAME. The PNS (8 Hz)-evoked NE release in the perfusate was increased by L-NAME perfusion. In preparations treated with capsaicin [a depleter of calcitonin gene-related peptide (CGRP)-containing nerves], L-NAME did not augment vasoconstrictor responses to PNS or NE injection. Combined perfusion of CGRP(8-37) (a CGRP receptor antagonist) and L-NAME induced additive augmentation of the vasoconstrictor response to PNS but did not affect the response to NE injection. In preparations with active tone produced by methoxamine and in the presence of guanethidine, L-NAME perfusion did not affect the vasodilator response induced by PNS. Immunostaining of the mesenteric artery showed the presence of nNOS-like immunopositive nerve fibers, which were absent in arteries pretreated with capsaicin. These findings suggest that NO, which is released from perivascular capsaicin-sensitive nerves, presynaptically inhibits neurogenic NE release to modulate adrenergic neurotransmission.
在无内皮的大鼠肠系膜血管床中,研究了非选择性一氧化氮合酶(NOS)抑制剂[N-ω-硝基-L-精氨酸甲酯(L-NAME)和N-ω-硝基-L-精氨酸(L-NNA)]以及特异性神经元型NOS(nNOS)抑制剂[乙烯基-L-N-5-(1-亚氨基-3-丁烯基)-L-鸟氨酸(L-VNIO)]对肾上腺素能神经介导的血管收缩的影响。灌注L-NAME、L-NNA或L-VNIO可显著增强对动脉周围神经刺激(PNS;2-8Hz)的血管收缩反应,而不影响外源性注射去甲肾上腺素(NE)所诱导的血管收缩。添加L-精氨酸(一氧化氮(NO)合成的前体)可逆转L-NAME对PNS反应的增强作用。灌注L-NAME可增加灌注液中PNS(8Hz)诱发的NE释放。在用辣椒素(一种降钙素基因相关肽(CGRP)能神经的耗竭剂)处理的制剂中,L-NAME不会增强对PNS或NE注射的血管收缩反应。联合灌注CGRP(8-37)(一种CGRP受体拮抗剂)和L-NAME可使对PNS的血管收缩反应产生相加性增强,但不影响对NE注射的反应。在用甲氧明产生主动张力且存在胍乙啶的制剂中,灌注L-NAME不影响PNS诱导的血管舒张反应。肠系膜动脉的免疫染色显示存在nNOS样免疫阳性神经纤维,在用辣椒素预处理的动脉中则不存在。这些发现表明,从血管周围对辣椒素敏感的神经释放的NO,在突触前抑制神经源性NE释放,从而调节肾上腺素能神经传递。